FDA Inspection 1157825 — New York Blood Center Inc
The FDA completed an inspection of New York Blood Center Inc on Oct 15, 2021 in Freehold, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 15, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Freehold, NJ (United States)